Switzerland· 62673001
Stribild, Filmtabletten
A emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat product containing elvitegravirum, cobicistatum, emtricitabinum, tenofovirum disoproxilum, registered in Switzerland by Gilead Sciences Switzerland Sàrl and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR09 (emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat · ATC J05AR09
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- elvitegravirum, cobicistatum, emtricitabinum, tenofovirum disoproxilum
- Manufacturer
- Gilead Sciences Switzerland Sàrl
- Country
- Switzerland (CH)
- ATC code
- J05AR09
- ATC class
- Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768062673001230 StkCHF 1055.35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandStribildOrifarm Oy
- CzechiaSTRIBILDGilead Sciences Ireland UC, Carrigtohill
- United KingdomStribild 150mg/150mg/200mg/245mg tabletsGilead Sciences Ltd
- IcelandStribildGilead Sciences Ireland UC*
- NorwayStribildGilead Sciences Ireland UC
- PolandStribildGilead Sciences Ireland UC
- SwedenStribild 150 mg/150 mg/200 mg/245 mg Filmdragerad tablettGilead Sciences Ireland UC
- CanadaSTRIBILDGILEAD SCIENCES CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Stribild
- Liechtenstein · Stribild
- Norway · Stribild
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f3e2c093-d4dd-4e91-8323-ff6da454177d GET /v1/drugs/f3e2c093-d4dd-4e91-8323-ff6da454177d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "elvitegravirum 150 mg + cobicistatum 150 mg + emtricitabinum 200 mg + tenofovirum disoproxilum 245 mg",
"valid_from": "2013-11-01",
"limitations": null,
"galenic_form": "Filmtabs 150/150/200/245 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2013-11-01",
"self_retention_pct": 10
}See everything about emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.